A carregar...
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
Given the median survival of 15 months after diagnosis, novel treatment strategies are needed for glioblastoma. Beta-blockers have been demonstrated to inhibit angiogenesis and tumor cell proliferation in various cancer types. The aim of this study was to systematically review the evidence on the ef...
Na minha lista:
| Publicado no: | Neurosurg Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035104/ https://ncbi.nlm.nih.gov/pubmed/32172480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10143-020-01277-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|